FLORES JESSICA 4
4 · Sabra Health Care REIT, Inc. · Filed Mar 26, 2026
Research Summary
AI-generated summary of this filing
Sabra Health (SBRA) EVP Jessica Flores Sells 15,231 Shares
What Happened
Jessica Flores, Executive Vice President & Chief Accounting Officer of Sabra Health Care REIT (SBRA), sold 15,231 shares of company common stock in open-market transactions on March 25, 2026. The weighted-average sale price was $19.86 per share, resulting in gross proceeds of approximately $302,488. This was a sale (not a purchase or option exercise), which is often routine insider selling and does not, by itself, indicate company outlook.
Key Details
- Transaction date: 2026-03-25 (filed with the SEC on 2026-03-26).
- Transaction type/code: Open-market sale (S).
- Shares sold: 15,231 at a weighted-average price of $19.86; proceeds ≈ $302,488.
- Price range: trades occurred at prices between $19.85 and $19.89 (footnote F1). The filer will provide a per-price breakdown on request.
- Filing timeliness: Report filed one day after the trade (appears timely).
- Notable filing note (F2): The filing also references 25,527 stock units that, upon settlement, will be paid one-for-one in Sabra common stock (these units are noted in the filing’s ownership disclosure).
Context
- Sales by executives can be for many reasons (diversification, personal liquidity, planned transactions) and are not definitive signals about company fundamentals.
- No options were exercised and no awards/gifts were reported in this filing; this report documents an outright sale of existing shares.
Insider Transaction Report
Form 4
FLORES JESSICA
Executive VP & CAO
Transactions
- Sale
Common Stock
[F1][F2]2026-03-25$19.86/sh−15,231$302,488→ 71,709 total
Footnotes (2)
- [F1]The price report in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.85 to $19.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Includes 25,527 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.
Signature
/s/ Michael Costa, as Attorney-in-Fact|2026-03-26